Palla Pharma Ltd
ASX:PAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Palla Pharma Ltd
ASX:PAL
|
AU |
|
Hualan Biological Engineering Inc
SZSE:002007
|
CN |
|
Z
|
Zedge Inc
AMEX:ZDGE
|
US |
|
CK Infrastructure Holdings Ltd
HKEX:1038
|
HK |
|
Security Matters Ltd
ASX:SMX
|
AU |
|
I
|
IT Tech Packaging Inc
AMEX:ITP
|
CN |
|
S
|
Samfine Creation Holdings Group Ltd
NASDAQ:SFHG
|
HK |
|
Nanoco Group PLC
LSE:NANO
|
UK |
|
Blackstone Secured Lending Fund
F:GM8
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PAL.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PAL Competitors Multiples
Palla Pharma Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Palla Pharma Ltd
ASX:PAL
|
47.8m AUD | 2.8 | -0.8 | -2 | -2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
951.1B USD | 333 | 3 943.2 | 1 129.9 | 2 175.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
186.1B USD | 4.2 | 27.8 | 19.3 | 25.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
134.9B USD | 5.5 | 37.3 | 19 | 27.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.6B CHF | 5.4 | 37.2 | 27.6 | 27.6 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
309.7B CNY | 6.8 | 16.2 | 16.9 | 16.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.4B USD | 4.6 | 25.1 | 18.5 | 21.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.4B USD | 9.3 | 45.7 | 29.5 | 37.1 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.2B USD | 1.8 | 21.6 | 12 | 18 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.9B USD | 6.4 | 29.8 | 22.1 | 24.6 |